Mineralocorticoid receptor (MR) antagonists are well established in the treatment of chronic left heart disease, however, there is an ever growing body of evidence suggesting potential benefits in other cardiovascular disease. Here, we evaluated the effects of MR antagonists on more…
The British Journal of Pharmacology will be publishing a special ‘Themed Issue’ entitled “Emerging fields for therapeutic targeting of the aldosterone-mineralocorticoid receptor signaling pathway” with Achim Lother, Ulrich Wenzel and Frédéric Jaisser as Guest Editors. Call for papers: https://bpspubs.onlinelibrary.wiley.com/hub/journal/14765381/aldosterone-mineralocorticoid.html
Both, antiviral treatment with remdesivir and hemoadsorption using a CytoSorb® adsorption device are applied in the treatment of severe COVID-19. The CytoSorb® adsorber consists of porous polymer beads that adsorb a broad range of molecules, including cytokines but also several more…
